The Supervisory Board hereby announces that Arthur de Bok resigned as CEO and will leave the company to pursue other career interests. Rob ter Haar, chairman of the Supervisory Board said: “Arthur has successfully led Mediq in a new strategic direction with a focus on growing the international Direct to Patient and Institutional businesses. To support this, the company has been transformed to bring much greater cooperation between the operating units, with better systems and processes. In parallel, Arthur oversaw the successful divestment of the Pharmacy business in the Netherlands. We wish him every success in his further career.”
Arthur de Bok: “Over the last three years, we have made tremendous progress in turning Mediq into a company that can provide better care at lower cost with better outcomes for chronic patients. I am proud of what we have accomplished and I am confident that the company’s future is bright.”
As the new CEO of Mediq, the Supervisory Board has appointed Christian Wojczewski who as general manager has successfully built the healthcare unit of the Linde Group into a € 3 billion turnover global business. Rob ter Haar: “The Supervisory Board is delighted that Christian has agreed to join Mediq as its CEO. He is a skilled executive with a proven track record in business transformation and brings a wealth of knowledge of healthcare distribution and homecare. Over the past years Mediq invested significantly in people and systems to build a platform for growth. We look forward to working with Christian in capitalizing on our organic growth potential whilst continuing our track record of successful acquisitions.”
Christian Wojczewski: “Mediq has successfully managed the transition into a leading player in institutional healthcare and homecare over the past years. I look forward continuing on the strategic path together with the management team and all Mediq employees.”
The transition of the leadership at Mediq will take place in April.